News Releases

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season

Four Viral Infections Have Similar Patient Presentations, Making Accurate Detection and Differentiation Critical During Next Flu Season

First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19

Enabling on-demand monitoring of BCR-ABL levels in patients with Chronic Myeloid Leukemia (CML)

On-Demand Same-Day Extragenital Testing for Chlamydia and Gonorrhea Fills Critical Unmet Need in Fight Against Rising Rates of Chlamydial and Gonorrheal Infection

SpeeDx is the First Trusted Reagent Manufacturer to launch a new test for use on the GeneXpert® System

Simplify Hepatitis B Treatment Management

Enables Hepatitis C Point-of-Care molecular testing and linkage to care

Respiratory Infection Results in as Little as 20 Minutes(1)

Xpert® Carba-R now FDA-cleared to aid clinicians in determining appropriate therapeutic strategy for pure colony specimens

Accurate and Reliable Group A Streptococcus Detection in as Little as 18 Minutes(1)

Updated guidelines reaffirm PCR as highly sensitive method for detecting deadly toxigenic C. difficile

Flu Results in as Little as 20 Minutes[1]

Accurate and Reliable Group A Strep Detection in as soon as 18 minutes(1)

Providing Rapid Molecular Diagnostic Results in as little as 20 minutes

Xpert® MRSA NxG Expands Strain Coverage to Address Evolving Threats

Why Choose Between Fast or Accurate When You Can Have Both?

Xpert Bladder Cancer Monitor Now Commercially Available

Binary Toxin Gene Reporting has Been Added to the Market Leading Xpert C. difficile Product

Enabling Accurate and Fast Molecular HIV Viral Load Test from Finger Stick Whole Blood